HYDRENS Trademark

Trademark Overview

On Monday, May 4, 2020, a trademark application was filed for HYDRENS with the United States Patent and Trademark Office. The USPTO has given the HYDRENS trademark a serial number of 88899942. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 29, 2024. This trademark is owned by QRSKIN USA, Inc.. The HYDRENS trademark is filed in the Pharmaceutical Products category with the following description:

Transdermal patches comprised of medications for the promotion of healthy skin; transdermal patches comprised of medications for increasing energy; transdermal patches comprised of medications to support relief of allergy symptoms; transdermal patches containing nutritional supplements; transdermal patches comprised of medications for pain relief; transdermal patches comprised of medications for treatment of premenstrual syndrome symptoms; transdermal patches comprised of medications to promote sleep; transdermal patches comprised of medications to support and promote weight loss; transdermal patches containing vitamin supplements; none of the foregoing comprised of Cannabis sativa L or cannabidiol (CBD)
hydrens

General Information

Serial Number88899942
Word MarkHYDRENS
Filing DateMonday, May 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2020

Trademark Statements

Goods and ServicesTransdermal patches comprised of medications for the promotion of healthy skin; transdermal patches comprised of medications for increasing energy; transdermal patches comprised of medications to support relief of allergy symptoms; transdermal patches containing nutritional supplements; transdermal patches comprised of medications for pain relief; transdermal patches comprised of medications for treatment of premenstrual syndrome symptoms; transdermal patches comprised of medications to promote sleep; transdermal patches comprised of medications to support and promote weight loss; transdermal patches containing vitamin supplements; none of the foregoing comprised of Cannabis sativa L or cannabidiol (CBD)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQRSKIN USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmers Branch, TX 75234
Party NameQRSKIN USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75201

Trademark Events

Event DateEvent Description
Monday, January 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2023SOU EXTENSION 5 GRANTED
Wednesday, June 7, 2023SOU EXTENSION 5 FILED
Wednesday, June 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 1, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2022SOU EXTENSION 4 GRANTED
Wednesday, December 28, 2022SOU EXTENSION 4 FILED
Wednesday, December 28, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 17, 2022SOU EXTENSION 3 GRANTED
Friday, June 17, 2022SOU EXTENSION 3 FILED
Friday, June 17, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 1, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 1, 2021SOU EXTENSION 2 FILED
Wednesday, December 1, 2021SOU TEAS EXTENSION RECEIVED
Saturday, May 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 13, 2021SOU EXTENSION 1 GRANTED
Thursday, May 13, 2021SOU EXTENSION 1 FILED
Thursday, May 13, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 14, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 29, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, September 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 29, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, September 29, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, September 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 28, 2020NON-FINAL ACTION E-MAILED
Monday, September 28, 2020NON-FINAL ACTION WRITTEN
Sunday, September 27, 2020ASSIGNED TO EXAMINER
Thursday, July 30, 2020ASSIGNED TO EXAMINER
Wednesday, July 29, 2020ASSIGNED TO EXAMINER
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 7, 2020NEW APPLICATION ENTERED

Related Keywords

hydrens patches transdermal comprised medications symptoms relief supplements promote containing support